Sam Gandy

Dr. Samuel E. Gandy is an international expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's.

In 1989, Gandy and his team discovered the first drugs that could lower formation of amyloid. Gandy has written more than 150 original papers, chapters and reviews on this topic. He has received continuous National Institutes of Health (NIH) funding for his research on amyloid metabolism since 1986.

Gandy is the Mount Sinai Professor of Alzheimer's Disease Research, Professor of Neurology and Psychiatry, Associate Director of the Mount Sinai Medical Center Alzheimer's Disease Research Center in New York City, and Chairman Emeritus of the National Medical and Scientific Advisory Council of the Alzheimer's Association. He received both his MD and PhD at the Medical University of South Carolina.

He did his postgraduate work at the Columbia University College of Physicians & Surgeons and Cornell University Medical College. Gandy completed his post-doctorate at Rockefeller University, where he was appointed assistant professor in the laboratory of Paul Greengard, 2000 Laureate of the Nobel Prize in Physiology or Medicine.

Gandy was appointed associate professor of neurology and neurosciences at Cornell University Medical College in 1992. In 1997, he moved to New York University where he served as professor of psychiatry and cell biology until his appointment as Paul C. Brucker, M.D., Professor of Neuroscience at Jefferson Medical College and Director of the Farber Institute for Neurosciences in 2001. In July 2007, he assumed his current post as Sinai Professor of Alzheimer’s Disease Research at the Mount Sinai School of Medicine. He is also a member of the Research Consortium of the Cure Alzheimer's Fund.

...
Wikipedia